Anti-metastatic action of an N4-aryl substituted thiosemicarbazone on advanced triple negative breast cancer.

Autor: A.M. Sólimo, M.C. Soraires Santacruz, S. Vanzulli, O. Coggiola, E. Bal de Kier Joffé, L. Finkielsztein, M.A. Callero

Publikováno v: Heliyon, Vol 6, Iss 10, Pp e05161- (2020)

Purpose: Advanced triple negative breast cancer (ATNBC) is defined by a lack of expression of hormones receptors as well as HER2/neu and its high probability of visceral metastasis. This pathology is associated with a poor prognosis. Previously, we f

Externí odkaz: https://doaj.org/article/87cc415fb0e142afa615eb9137c4ac94

Anti-metastatic action of an N4-aryl substituted thiosemicarbazone on advanced triple negative breast cancer

Autor: Aldana Sólimo, M.C. Soraires Santacruz, S. Vanzulli, E. Bal de Kier Joffé, Mariana A. Callero, Liliana M. Finkielsztein, O. Coggiola

Publikováno v: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Heliyon
Heliyon, Vol 6, Iss 10, Pp e05161-(2020)

Purpose Advanced triple negative breast cancer (ATNBC) is defined by a lack of expression of hormones receptors as well as HER2/neu and its high probability of visceral metastasis. This pathology is associated with a poor prognosis. Previously, we fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbbd43439250569b8a53e9963b7985a
https://www.cell.com/heliyon/fulltext/S2405-8440(20)32004-1?_returnURL=https://linkinghub.elsevier.com/retrieve/pii/S2405844020320041?showall=true

Contents, Vol. 15, 1994

Autor: C. Elías, Masashi Hori, Judith Jo, Rachel J. Quin, Bruce G. Ward, Mathias Onsrud, J Joseph, Rafael Molina, Jiro Fujimoto, Michael A. McGuckin, Gene P. Siegal, Raj Kumar Singh, Ayman Shabana, S.R. Leicach, L. Puricelli, Teruhiko Tamaya, Lyndon J. Goodly, Ana María Eiján, Miki Nishigaki, M. Wang, Satoshi Ichigo, Yrjö Collan, E. Bal de Kier Joffé, Nuria Giménez, R.A. Cadenas, Carles Agusti, Antonio M. Ballesta, Xavier Filella, Riikka Huovinen, Peter L. Devine

Publikováno v: Tumor Biology. 15:I-X

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a4c3796e31924914964d1c997041c73
https://doi.org/10.1159/000217906

Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model

Autor: Jorge Filmus, Lydia Puricelli, Eduardo F. Farías, María Giselle Peters, E. Bal de Kier Joffé, Lucas L. Colombo

Publikováno v: Breast cancer research and treatment. 80(2)

Glypican-3 (GPC3), a proteoglycan bound to the cell membrane through a GPI anchor, is widely expressed in the embryo but down regulated in most adult tissues, with some exceptions as mammary cells. GPC3 is involved in the regulation of cell prolifera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e176b7b06b7d81ad890be9df2f34ec04
https://pubmed.ncbi.nlm.nih.gov/12908826

Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells

Autor: E F, Farías, J A, Aguirre Ghiso, V, Ladeda, E, Bal de Kier Joffé

Publikováno v: International journal of cancer. 78(6)

The invasion and metastasis process involves degradation of the extracellular matrix mediated by tumor- and host-produced proteolytic enzymes. The main enzymes involved in this process are urokinase-type plasminogen activator (uPA) and the matrix met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ed5abb28ef466c021d0215514c18febd
https://pubmed.ncbi.nlm.nih.gov/9833766